Boswellia
Specifically for Psoriasis
0 up • 0 down
Why it works for Psoriasis:
Lowers leukotrienes (5-LOX inhibition): Boswellic acids—especially AKBA—directly inhibit 5-lipoxygenase, reducing leukotriene-driven inflammation implicated in psoriatic skin. ScienceDirect
Damps pro-inflammatory signalling (NF-κB) & neutrophil enzymes: Boswellic acids can inhibit NF-κB signalling and human leukocyte elastase, both relevant to psoriatic plaque inflammation and scaling. Dove Medical Press
Keratinocyte/immune metabolism effects: Preclinical work identifies AKBA as an inhibitor of MAT2A (one-carbon metabolism), improving psoriasis-like inflammation in mice and suggesting a keratinocyte-centric mechanism. Europe PMC
How to use for Psoriasis:
Topical Boswellia (the form with clinical data in psoriasis):
- Cream/gel with Boswellia extract applied twice daily for 4 weeks to plaques improved erythema and scaling versus placebo in small randomized trials. One double-blind study used a Boswellia-based cream (Bosexil®) twice daily for 30 days; another randomized, triple-blind trial used a Boswellia-based multi-herb cream twice daily for 4 weeks. Dove Medical Press
Practical application tips (from trial protocols & standard derm practice):
- Apply a thin layer to intact skin on affected plaques BID (morning/evening). Avoid broken skin and the eyes. If irritation occurs, stop and reassess. Dove Medical Press
- Use as an adjunct to your dermatologist’s regimen (e.g., between steroid or vitamin-D analog courses), not as a replacement for prescribed therapy. Evidence to date is for short courses (≈4 weeks); long-term data are lacking. Dove Medical Press
Oral Boswellia: There are no psoriasis-specific RCTs of oral Boswellia. Typical oral doses used for other inflammatory conditions are 300–500 mg standardized extract (often 60–65% boswellic acids) two to three times daily, but psoriasis efficacy with oral dosing hasn’t been established—speak with your clinician before considering it. Medscape
Scientific Evidence for Psoriasis:
Human (psoriasis-focused)
- Double-blind RCT (Italy, 2014): A Boswellia-based cream (Bosexil®) vs placebo for 30 days in patients with psoriasis or eczema; psoriatic scales and erythema improved with Boswellia vs placebo (no worsening cases reported). Small sample; industry involvement; 30-day follow-up. Dove Medical Press
- Randomized, triple-blind, vehicle-controlled trial (Iran, 2022): 108 adults with mild-to-moderate plaque psoriasis received a Boswellia-based multi-herb cream (Boswellia extract + oil, licorice extract, pumpkin oil) BID for 4 weeks; greater PASI reduction and QoL improvement vs vehicle. (Combination product; 4-week horizon.) Directory of Open Access Journals
Preclinical / mechanistic (supportive, not proof)
- AKBA → MAT2A inhibition & metabolic reprogramming: Identified keratinocyte target (MAT2A) with symptomatic improvement in an imiquimod mouse model when topical AKBA was used. Europe PMC
- Core anti-inflammatory actions: 5-LOX inhibition by AKBA; leukocyte elastase inhibition; additional anti-inflammatory signalling effects. ScienceDirect
- Scope review: A 2022 scoping review catalogs in-vitro/in-vivo/clinical Boswellia work across conditions; dermatology evidence remains limited. ScienceDirect
Specific Warnings for Psoriasis:
Not a substitute for standard care: Use as adjunctive therapy; discuss with a dermatologist, especially for moderate–severe psoriasis or psoriatic arthritis. NCCIH
Skin reactions: Topicals can cause contact irritation or allergy; discontinue if redness/burning worsens. (Trial safety data show good short-term tolerability, but experience is limited.) Dove Medical Press
Pregnancy & breastfeeding: Insufficient safety data—avoid unless your clinician advises otherwise. NCCIH
Drug interactions (oral products):
- May interact with anticoagulants/antiplatelets (e.g., warfarin) and potentially with CYP-metabolized drugs; theoretical increased bleeding or altered drug levels—consult your doctor/pharmacist. Hello Pharmacist
- Check comprehensive interaction lists if you take prescription meds. Drugs.com
Common side effects (oral): GI upset (nausea, reflux), diarrhea, rash; rare reports of liver enzyme abnormalities—monitor if you have liver disease or take hepatically-metabolized drugs. WebMD
Surgery/bleeding risk: Stop oral Boswellia 1–2 weeks before surgery due to theoretical bleeding risk. NCCIH
General Information (All Ailments)
What It Is
Boswellia, also known as Indian frankincense, is a resin extracted from the bark of trees in the Boswellia genus — particularly Boswellia serrata. The resin has been used for centuries in traditional Ayurvedic and Chinese medicine to treat various inflammatory conditions.
The active compounds in Boswellia are boswellic acids, including acetyl-11-keto-β-boswellic acid (AKBA), which is believed to be primarily responsible for its therapeutic effects.
Boswellia is commonly available in:
- Resin form (for burning or topical use)
- Capsules or tablets (standardized extracts)
- Creams and ointments (for joint pain)
- Essential oils (for aromatherapy or topical applications)
How It Works
Boswellia works mainly by modulating the body’s inflammatory response through several biochemical pathways:
- Inhibition of 5-Lipoxygenase (5-LOX):
- Boswellic acids block the enzyme 5-LOX, which is involved in the production of leukotrienes — inflammatory molecules that play a role in asthma, arthritis, and inflammatory bowel diseases.
- Reduction of Pro-inflammatory Cytokines:
- It helps reduce levels of inflammatory mediators like tumor necrosis factor-alpha (TNF-α) and interleukins (IL-1β, IL-6).
- Prevention of Cartilage Breakdown:
- Boswellia may help protect joint cartilage by inhibiting enzymes (such as MMPs) that degrade connective tissue, making it useful for osteoarthritis.
- Antioxidant and Immunomodulatory Effects:
- Boswellia also exerts antioxidant actions that help reduce oxidative stress and may improve overall immune function.
Why It’s Important
Boswellia has attracted modern scientific interest because it provides natural anti-inflammatory effects comparable to some nonsteroidal anti-inflammatory drugs (NSAIDs), but with fewer gastrointestinal side effects.
Key potential benefits include:
- Joint Health: May improve flexibility and reduce pain and swelling in osteoarthritis and rheumatoid arthritis.
- Respiratory Support: Helps manage asthma and bronchial inflammation.
- Digestive Health: May reduce symptoms of inflammatory bowel diseases (Crohn’s disease, ulcerative colitis).
- Brain and Cognitive Function: Early research suggests potential neuroprotective effects, possibly beneficial in neuroinflammatory conditions.
- Overall Well-being: Because chronic inflammation is linked to many diseases, Boswellia’s modulation of inflammatory pathways supports systemic health.
Considerations
While Boswellia is generally well tolerated, there are important factors to consider:
1. Safety and Side Effects
- Common side effects are mild and may include nausea, diarrhea, acid reflux, or skin rashes.
- Rarely, allergic reactions may occur.
- Long-term high-dose use has not been extensively studied.
2. Interactions
- May interact with anti-inflammatory or anticoagulant medications (e.g., NSAIDs, warfarin).
- Should be used cautiously with other herbs or supplements affecting inflammation or the immune system.
3. Dosage and Standardization
- Typical doses of Boswellia serrata extract range from 300–500 mg, taken 2–3 times daily, standardized to contain 30–65% boswellic acids.
- Consistency in formulation is crucial, as potency can vary widely among products.
4. Pregnancy and Medical Conditions
- Not enough research exists to confirm safety during pregnancy or breastfeeding.
- People with gastrointestinal conditions or taking medications should consult a healthcare professional before use.
5. Quality and Purity
- Look for standardized extracts (e.g., 65% boswellic acids or specific AKBA content).
- Choose products tested for contaminants (heavy metals, adulteration).
Helps with these conditions
Boswellia is most effective for general wellness support with emerging research . The effectiveness varies by condition based on clinical evidence and user experiences.
Detailed Information by Condition
Crohn's Disease
Boswellia's therapeutic potential in Crohn’s disease is primarily attributed to its active compounds, particularly boswellic acids, which are believed...
Arthritis
The active molecules in Boswellia (boswellic acids — especially 3-O-acetyl-11-keto-β-boswellic acid, AKA AKBA) inhibit 5-lipoxygenase (5-LOX), an enzy...
Back Pain
Boswellia’s main actives (boswellic acids—especially AKBA) inhibit 5-lipoxygenase (5-LOX) and reduce leukotriene production, key mediators of inflamma...
Asthma
Targets leukotrienes (inflammation pathway central to asthma). A key boswellia constituent—AKBA (3-acetyl-11-keto-β-boswellic acid)—directly inhibits...
Diverticulitis
Anti-inflammatory mechanism: The most active Boswellia constituents (boswellic acids — especially 3-O-acetyl-11-keto-β-boswellic acid, AKBA) inhibit 5...
Sciatica
Sciatica pain is most often driven by inflammation around a compressed or irritated lumbar nerve root. Boswellia’s major acids—especially AKBA (acetyl...
Psoriasis
Lowers leukotrienes (5-LOX inhibition): Boswellic acids—especially AKBA—directly inhibit 5-lipoxygenase, reducing leukotriene-driven inflammation impl...
Rheumatoid Arthritis
Anti-inflammatory pathways: Boswellic acids—especially AKBA (3-O-acetyl-11-keto-β-boswellic acid)—inhibit 5-lipoxygenase (5-LOX), lowering leukotriene...
Tendonitis
Boswellia has plausible anti-inflammatory mechanisms and decent human data for joint pain (especially osteoarthritis). Direct, high-quality trials for...
Carpal Tunnel Syndrome
Anti-inflammatory mechanism: Boswellic acids—especially AKBA (acetyl-11-keto-β-boswellic acid)—are direct, non-redox inhibitors of 5-lipoxygenase (5-L...
Multiple Sclerosis
Leukotriene pathway / 5-lipoxygenase (5-LOX) inhibition. The main boswellic acid, AKBA, is an allosteric inhibitor of 5-LOX, a key enzyme in leukotrie...
Temporomandibular Joint Disorder
It targets the leukotriene pathway (5-LOX). The most active boswellic acid (AKBA) directly inhibits 5-lipoxygenase, lowering leukotrienes that drive i...
Rheumatoid Osteoarthritis
Leukotriene pathway inhibition (5-LOX): AKBA (3-acetyl-11-keto-β-boswellic acid), a key boswellic acid, directly inhibits 5-lipoxygenase, lowering pro...
Pleurisy
Boswellia (Indian frankincense, Boswellia serrata) has well-documented anti-inflammatory actions (notably via boswellic acids such as AKBA inhibiting...
Community Discussion
Share results, tips, and questions about Boswellia.
Loading discussion...
No comments yet. Be the first to start the conversation!
Discussion for Psoriasis
Talk specifically about using Boswellia for Psoriasis.
Loading discussion...
No comments yet. Be the first to start the conversation!
Remedy Statistics
Helps With These Conditions
Recommended Products
No recommended products added yet.